Blog _Blog The APQR review “à la française” Read more » February 1, 2023 _Blog The consulting profession at ATESSIA Read more » January 24, 2023 _Blog The mysterious thing that an Exploitant is Read more » July 7, 2022 _Blog Registering gene therapy medicinal products Read more » June 23, 2022 _Blog How to manage a non-GMP raw material in your MA files? Read more » June 20, 2022 _Blog How to proceed with non-pharmacopoeial excipients in the formulation of a medicinal product for human use? Read more » June 15, 2022 _Blog Do “over the counter” medicines exist in France? Read more » June 2, 2022 _Blog The French version of the former anti-gift law Read more » May 26, 2022 _Blog LunchWork Atessia 11/05/22 “Nitrosamines: Final stretch to meet the deadlines” Read more » May 13, 2022 _Blog LunchWork Atessia x LexCase 20/04/22 “Quality charter of professional practices for reimbursable products and services” Read more » May 2, 2022 Page1 Page2 Page3 Page4
_Blog How to proceed with non-pharmacopoeial excipients in the formulation of a medicinal product for human use? Read more » June 15, 2022
_Blog LunchWork Atessia 11/05/22 “Nitrosamines: Final stretch to meet the deadlines” Read more » May 13, 2022
_Blog LunchWork Atessia x LexCase 20/04/22 “Quality charter of professional practices for reimbursable products and services” Read more » May 2, 2022
